Sputum cell counts and FeNO levels in patients treated with anti-IgE and anti-IL-5 /IL-5R: Evidence for a dissociation between sputum eosinophil counts and FeNO levels

被引：0
|
作者：
Sabbe, Mare [1 ]
Schleich, Florence [1 ]
Bougard, Nicolas [1 ]
Moermans, Catherine [1 ]
Henquet, Monique [1 ]
Guissard, Francoise [1 ]
Sanschez, Carole [1 ]
Paulus, Virginie [1 ]
Louis, Renaud [1 ]
机构：
[1] CHU Iiege, Liege, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA989
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 24 条
  • [1] Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline
    Gerday, Sara
    Graff, Sophie
    Moermans, Catherine
    Guissard, Francoise
    Paulus, Virginie
    Henket, Monique
    Louis, Renaud
    Schleich, Florence
    THORAX, 2023, 78 (11) : 1138 - 1141
  • [2] Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma
    Menigoz, C.
    Dirou, S.
    Chambellan, A.
    Hassoun, D.
    Moui, A.
    Magnan, A.
    Blanc, F. X.
    JOURNAL OF ASTHMA, 2023, 60 (06) : 1162 - 1170
  • [3] Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.
    Saji, Junko
    Muraoka, Hiromi
    Nishimoto, Eriko
    Matsuzawa, Shin
    Okamoto, Mariko
    Inoue, Teppei
    Handa, Hiroshi
    Nishine, Hiroki
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma
    Hekking, Pieter-Paul
    Zhang, Kayla
    Garrido, Carmen Paz Venegas
    Lopez-Rodriguez, Raquel
    Kjarsgaard, Melanie
    Mukherjee, Manali
    Nair, Parameswaran
    ALLERGY, 2024, 79 (08) : 2244 - 2247
  • [5] Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels
    Simpson, JL
    Timmins, NL
    Fakes, K
    Talbot, PI
    Gibson, PG
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (05) : 759 - 762
  • [6] Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5
    Moermans, Catherine
    Brion, Chloe
    Bock, Gregory
    Graff, Sophie
    Gerday, Sara
    Nekoee, Haleh
    Poulet, Christophe
    Bricmont, Noemie
    Henket, Monique
    Paulus, Virginie
    Guissard, Francoise
    Louis, Renaud
    Schleich, Florence
    CHEST, 2023, 163 (06) : 1368 - 1379
  • [7] Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
    Stein, Miguel L.
    Villanueva, Joyce M.
    Buckmeier, Bridget K.
    Yamada, Yoshiyuki
    Filipovich, Alexandra H.
    Assa'ad, Amal H.
    Rothenberg, Marc E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) : 1473 - 1483
  • [8] Real World Effectiveness of Anti-IL-5/5R Therapies Is Independent of Co-Eligibility for Anti-IgE Therapy
    Hearn, A.
    Hug, D.
    Somani, Z. A.
    Kavanagh, J.
    D'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Kent, B. D.
    Dhariwal, J.
    Nanzer, A.
    Jackson, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy
    Hearn, Andrew P.
    Hug, Oliver D.
    Somani, Ziana A.
    Kavanagh, Joanne
    d'Ancona, Grainne
    Roxas, Cris
    Green, Linda
    Thomson, Louise
    Fernandes, Mariana
    Kent, Brian D.
    Dhariwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (06)
  • [10] Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
    Gevaert, Philippe
    Lang-Loidolt, Doris
    Lackner, Andreas
    Stammberger, Heinz
    Staudinger, Heribert
    Van Zele, Thibaut
    Holtappels, Gabriele
    Tavernier, Jan
    van Cauwenberge, Paul
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (05) : 1133 - 1141
123